Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.

Ogu UO, Mukhopadhyay A, Patel K, Nelson MN, Strahan KS, Wu L, Smeltzer MP, Ataga KI.

Open source

DOI
10.1111/ejh.14138
Published
2023-11-29
Container
Eur J Haematol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ejh.14138,
  title = {Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.},
  author = {Ogu UO and  Mukhopadhyay A and  Patel K and  Nelson MN and  Strahan KS and  Wu L and  Smeltzer MP and  Ataga KI.},
  year = {2024},
  journal = {Eur J Haematol},
  doi = {10.1111/ejh.14138},
  url = {https://doi.org/10.1111/ejh.14138}
}

RIS

TY  - JOUR
TI  - Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.
AU  - Ogu UO
AU  -  Mukhopadhyay A
AU  -  Patel K
AU  -  Nelson MN
AU  -  Strahan KS
AU  -  Wu L
AU  -  Smeltzer MP
AU  -  Ataga KI.
PY  - 2024
JO  - Eur J Haematol
DO  - 10.1111/ejh.14138
UR  - https://doi.org/10.1111/ejh.14138
ER  - 

APA

UO, O., A, M., K, P., MN, N., KS, S., L, W., MP, S., & KI., A. (2024). Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease.. Eur J Haematol. https://doi.org/10.1111/ejh.14138

Source records